Kraig Biocraft Laboratories is Testing Its Big Red(TM) Genetically Engineered Spider Silk
April 22 2014 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, today
announced that the Company received its fiber testing equipment,
including customized components, to test its latest genetically
engineered prototype fiber, Big Red™.
The Company announced that it created Big Red™, a new
genetically engineered silk fiber, last fall, by using spider silk
gene sequences. Preliminary testing indicated that Big Red™ might
have properties of strength and flexibility that could have
potential commercial applications.
The Company ordered testing equipment to verify the preliminary
results and, after taking delivery, had the equipment customized to
account for the unique nature of recombinant spider silk based
fibers.
"We are excited to perform a more rigorous evaluation of Big
Red™ spider silk with the new equipment. We are hopeful of having
definitive test results within the next several weeks. So far,
we are seeing a lot of variability, which may be an indication of
genetic variation within the transgenic colony. Not only will
these tests provide us the first comprehensive set of data
concerning Big Red™, and potentially guide us in improving that
transgenic, but it's also the first major assessment of the new
equipment," said Company founder and CEO, Kim Thompson.
The Company intends to use the testing equipment to increase the
laboratory's research and development effectiveness by providing
researchers with more rapid feedback on the results of their
work. The ability to quickly gather and analyze data is
expected to greatly improve the effectiveness of the Company's
ongoing work in artificial selection of various strains of
transgenic silkworms and potentially reduce the commercialization
timeline for future fibers.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company, is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024